Comprehensive analysis of the lncRNA‑associated competing endogenous RNA network in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comprehensive analysis of the lncRNA‑associated competing endogenous RNA network in breast cancer

Published:2019-10-15 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Wang Jing‑Jing¹,Huang Yue‑Qing²,Song Wei³,Li Yi‑Fan⁴,Wang Han⁵,Wang Wen‑Jie⁶,Huang Min²

Affiliation:

1. Department of Oncology, Taizhou Hospital of Traditional Chinese Medicine, Taizhou, Jiangsu 225300, P.R. China

2. Department of General Practice, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China

3. Department of Intervention and Vascular Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China

4. Department of Oncology, Binzhou People's Hospital, Binzhou, Shandong 256600, P.R. China

5. Department of Oncology, Jining Cancer Hospital, Jining, Shandong 272000, P.R. China

6. Department of Radio‑Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and validation of the TRHDE‐AS1/hsa‐miR‐449a/ADAMTS5 axis as a novel prognostic biomarker in prostate cancer;BioFactors;2024-05-31

2. LncRNA LINC00466 Promotes the Progression of Breast Cancer via miR-4731-5p/EPHA2 Pathway;Current Pharmaceutical Biotechnology;2024-05-09

3. Exploring the multifaceted role of RASGRP1 in disease: immune, neural, metabolic, and oncogenic perspectives;Cell Cycle;2024-03-18

4. Long non-coding RNA MEG3 acts as a suppressor in breast cancer by regulating miR-330/CNN1;Aging;2024-01-17

5. lncRNA-microRNA axis in cancer drug resistance: particular focus on signaling pathways;Medical Oncology;2024-01-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3